iRhythm Technologies, Inc. · 1 day ago
System Engineer II
iRhythm Technologies, Inc. is a leading digital healthcare company focused on cardiac health solutions. As a Systems Engineer II, you will develop and improve test solutions for wearable medical devices while collaborating with various engineering disciplines to ensure product reliability and quality.
Health CareHealth DiagnosticsMedical DevicemHealthWearables
Responsibilities
Collaborate cross-functionally with R&D, manufacturing, and product development teams to design and improve test fixtures and systems
Develop automated test processes and procedures to support verification, validation, and manufacturing activities
Create and maintain technical documentation, including Test Plans, System Requirements, and Test Reports
Analyze test data, derive limits, and verify capability using statistical tools (e.g., GR&R studies)
Utilize bench-top equipment such as power supplies, digital multimeters (DMMs), and oscilloscopes for system evaluation and debugging
Read and interpret circuit board schematics and layouts
Ensure all work complies with applicable medical device regulatory standards and internal quality system procedures
Qualification
Required
Bachelor's degree in Electrical Engineering, Biomedical Engineering, or related field (Master's preferred)
3–5 years of relevant engineering experience in system test, manufacturing test, or product development
Proficiency in Python or C# for test automation and data analysis
Strong understanding of test instrumentation and measurement principles
Excellent documentation, organizational, and communication skills
Preferred
Experience with electromechanical or wearable medical devices
Prior work in a regulated manufacturing or medical device environment
Experience with design of experiments (DOE), statistical analysis, or measurement system analysis (MSA)
Familiarity with ISO 13485, FDA 21 CFR Part 820, or similar quality system standards
Benefits
Competitive benefits
Company
iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease.
Funding
Current Stage
Public CompanyTotal Funding
$1.18BKey Investors
BraidwellNovo HoldingsNorwest
2024-03-04Post Ipo Debt· $643.6M
2020-08-21Post Ipo Secondary· $220M
2019-09-11Post Ipo Equity· $115M
Recent News
2026-01-07
GlobeNewswire
2025-12-08
Company data provided by crunchbase